Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.27 trillion and total revenue of $115.82 billion.
Market Cap
1.27T
Revenue
115.82B
Profits
-36.07B
PE Ratio
n/a
Profit Margin
-31.14%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 128.44B | -3.07% | 1,194,639 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 75.43B | -1.89% | 15,437,002 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 73.37B | -3.09% | 1,042,866 | 15.53B |
| 4 | ARGX | argenx SE | 59.26B | -2.39% | 302,247 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 44.13B | 0.31% | 2,104,484 | - |
| 6 | ONC | BeOne Medicines AG | 40.79B | -1.96% | 351,445 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 33.14B | -1.25% | 3,245,266 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.93B | -6.31% | 2,017,407 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.64B | -2.93% | 3,271,969 | 7.53M |
| 10 | BNTX | BioNTech SE | 24.33B | -1.48% | 820,114 | 3.03B |
| 11 | INCY | Incyte Corporation | 23.74B | -3.47% | 2,364,882 | 5.82B |
| 12 | INSM | Insmed Incorporated | 23.71B | -4.86% | 2,646,513 | 1.14B |
| 13 | GMAB | Genmab A/S | 20.81B | -3.17% | 6,377,009 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.13B | 0.64% | 740,577 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 14.93B | -0.23% | 805,981 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.36B | -0.80% | 1,369,461 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.31B | -1.30% | 7,900,982 | - |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.08B | 1.69% | 3,550,067 | 713.07M |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.33B | -1.05% | 878,989 | 830.81M |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.14B | -3.13% | 2,329,142 | 1.66B |
| 21 | TWST | Twist Bioscience Corporation | 11.79B | -2.69% | 3,117,105 | 431.80M |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.55B | -0.84% | 204,564 | 1.28B |
| 23 | TECH | Bio-Techne Corporation | 11.35B | -0.10% | 2,711,406 | 1.22B |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 11.31B | -2.60% | 2,083,190 | 3.41B |
| 25 | IBRX | ImmunityBio, Inc. | 9.84B | -1.69% | 12,313,726 | 165.79M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.63B | -2.18% | 225,736 | 440.48M |
| 27 | AXSM | Axsome Therapeutics, Inc. | 9.54B | -1.26% | 660,337 | 776.57M |
| 28 | KYMR | Kymera Therapeutics, Inc. | 9.16B | -1.49% | 1,051,067 | 105.00M |
| 29 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.15B | -1.01% | 1,522,235 | 669.50M |
| 30 | CYTK | Cytokinetics, Incorporated | 9.12B | -0.44% | 1,724,383 | 67.67M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.01B | -1.21% | 886,246 | 281.99M |
| 32 | PCVX | Vaxcyte, Inc. | 8.34B | -1.49% | 1,166,263 | - |
| 33 | ABVX | ABIVAX Société Anonyme | 8.26B | -3.96% | 1,244,403 | 5.33M |
| 34 | CAI | Caris Life Sciences, Inc. | 8.01B | -7.44% | 4,407,375 | 989.61M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 8.01B | -1.48% | 381,651 | 7.46M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 7.93B | 1.01% | 1,662,581 | - |
| 37 | TGTX | TG Therapeutics, Inc. | 7.61B | -3.87% | 2,122,671 | 799.54M |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.31B | -1.46% | 2,030,330 | 874.09M |
| 39 | IMVT | Immunovant, Inc. | 6.95B | -0.38% | 1,671,766 | - |
| 40 | BLTE | Belite Bio, Inc | 6.56B | -4.03% | 198,813 | - |
| 41 | IOVA | Iovance Biotherapeutics, Inc. | 6.45B | -3.98% | 15,967,863 | 324.97M |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.43B | -1.90% | 850,608 | 239.92M |
| 43 | KOD | Kodiak Sciences Inc. | 6.18B | 3.86% | 3,794,720 | - |
| 44 | CGON | CG Oncology, Inc. | 6.06B | -3.58% | 984,867 | 6.23M |
| 45 | LGND | Ligand Pharmaceuticals Incorporated | 6.04B | -3.08% | 374,020 | 290.54M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.62B | -4.47% | 1,061,617 | - |
| 47 | ORKA | Oruka Therapeutics, Inc. | 5.52B | 0.16% | 921,020 | - |
| 48 | COGT | Cogent Biosciences, Inc. | 5.48B | -1.34% | 1,698,631 | - |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 5.45B | -1.82% | 641,935 | 618.07M |
| 50 | CRSP | CRISPR Therapeutics AG | 5.36B | 0.22% | 1,058,271 | 13.39M |
| 51 | TVTX | Travere Therapeutics, Inc. | 5.36B | -3.45% | 2,394,618 | 591.33M |
| 52 | PTCT | PTC Therapeutics, Inc. | 5.35B | -1.00% | 1,197,752 | 1.01B |
| 53 | ERAS | Erasca, Inc. | 5.10B | -0.55% | 3,691,663 | - |
| 54 | DFTX | Definium Therapeutics, Inc. | 5.05B | -1.21% | 2,121,144 | - |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.94B | 0.31% | 767,034 | 1.90M |
| 56 | MANE | Veradermics, Incorporated | 4.90B | -3.31% | 660,187 | - |
| 57 | ABCL | AbCellera Biologics Inc. | 4.51B | -4.66% | 7,788,588 | 66.17M |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.40B | -0.30% | 1,286,684 | - |
| 59 | TNGX | Tango Therapeutics, Inc. | 4.12B | -2.00% | 2,910,264 | 53.81M |
| 60 | RLAY | Relay Therapeutics, Inc. | 4.05B | 2.44% | 2,824,168 | 10.35M |
| 61 | XENE | Xenon Pharmaceuticals Inc. | 3.77B | 4.68% | 3,660,477 | 7.50M |
| 62 | PBLS | Parabilis Medicines, Inc. | 3.76B | -5.73% | 885,843 | 148.00K |
| 63 | LEGN | Legend Biotech Corporation | 3.74B | -2.87% | 2,223,710 | 1.27B |
| 64 | CELC | Celcuity Inc. | 3.68B | -5.52% | 1,096,888 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.67B | -2.28% | 201,808 | 890.79M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.65B | -1.59% | 712,274 | 234.13M |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.56B | -6.41% | 6,831,968 | - |
| 68 | ACAD | Acadia Pharmaceuticals Inc. | 3.43B | -1.29% | 2,731,697 | 1.14B |
| 69 | ELVN | Enliven Therapeutics, Inc. | 3.39B | 0.81% | 944,890 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.31B | -4.01% | 1,242,147 | 606.33M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.28B | -0.68% | 1,939,763 | 3.60M |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.21B | -2.32% | 1,362,745 | 117.00M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 3.18B | -4.31% | 1,637,458 | 463.98M |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.95B | -1.80% | 3,699,425 | - |
| 75 | PGEN | Precigen, Inc. | 2.94B | -4.09% | 4,613,739 | 85.72M |
| 76 | NAMS | NewAmsterdam Pharma Company N.V. | 2.89B | -0.66% | 1,628,338 | 7.12M |
| 77 | ZLAB | Zai Lab Limited | 2.86B | -3.19% | 545,229 | 449.61M |
| 78 | MBX | MBX Biosciences, Inc. | 2.72B | -3.53% | 434,149 | - |
| 79 | CLDX | Celldex Therapeutics, Inc. | 2.53B | -0.71% | 1,443,330 | 158.00K |
| 80 | IRON | Disc Medicine, Inc. | 2.44B | -2.83% | 771,838 | - |
| 81 | BEAM | Beam Therapeutics Inc. | 2.44B | -0.25% | 1,695,438 | 156.04M |
| 82 | NRIX | Nurix Therapeutics, Inc. | 2.42B | -1.56% | 1,334,903 | 36.77M |
| 83 | IMNM | Immunome, Inc. | 2.37B | -2.88% | 1,096,833 | 4.02M |
| 84 | HRMY | Harmony Biosciences Holdings, Inc. | 2.30B | 0.79% | 1,227,745 | 959.90M |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -7.96% | 6,227,229 | - |
| 86 | VERA | Vera Therapeutics, Inc. | 2.23B | -4.03% | 1,009,595 | - |
| 87 | ADMA | ADMA Biologics, Inc. | 2.22B | -1.00% | 3,969,777 | 512.28M |
| 88 | ADRX | ADARx Pharmaceuticals, Inc. | 2.19B | -2.01% | 962,225 | 6.13M |
| 89 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | -1.45% | 17,484,139 | 54.86M |
| 90 | PHVS | Pharvaris N.V. | 2.18B | -2.24% | 654,347 | - |
| 91 | VRDN | Viridian Therapeutics, Inc. | 2.15B | -7.77% | 3,375,341 | 71.13M |
| 92 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | -1.54% | 934,033 | 311.51M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.10B | -5.61% | 1,654,616 | - |
| 94 | GPCR | Structure Therapeutics Inc. | 2.07B | -7.32% | 2,592,805 | - |
| 95 | TRVI | Trevi Therapeutics, Inc. | 2.02B | -0.98% | 3,145,315 | - |
| 96 | VCEL | Vericel Corporation | 2.02B | -1.74% | 497,333 | 306.30M |
| 97 | BHVN | Biohaven Ltd. | 1.98B | -1.57% | 1,507,227 | - |
| 98 | URGN | UroGen Pharma Ltd. | 1.98B | -0.20% | 624,625 | 188.73M |
| 99 | NUVB | Nuvation Bio Inc. | 1.95B | -0.71% | 3,471,515 | 169.90M |
| 100 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.95B | -2.09% | 4,340,481 | 208.78M |
| 101 | AGIO | Agios Pharmaceuticals, Inc. | 1.94B | -2.32% | 1,703,750 | 98.34M |
| 102 | PVLA | Palvella Therapeutics, Inc. | 1.91B | -3.77% | 343,370 | - |
| 103 | VIR | Vir Biotechnology, Inc. | 1.91B | 0.98% | 2,575,792 | 303.23M |
| 104 | LKFT | Lakefront Biotherapeutics NV | 1.88B | -2.66% | 341,548 | 1.13B |
| 105 | MESO | Mesoblast Limited | 1.86B | -2.25% | 332,306 | 120.25M |
| 106 | SRPT | Sarepta Therapeutics, Inc. | 1.86B | -3.57% | 2,885,279 | 1.97B |
| 107 | FTRE | Fortrea Holdings Inc. | 1.84B | -2.76% | 1,942,461 | 2.68B |
| 108 | ABSI | Absci Corporation | 1.84B | -0.19% | 4,608,584 | 1.56M |
| 109 | ZYME | Zymeworks Inc. | 1.84B | -2.00% | 808,703 | 37.13M |
| 110 | XNCR | Xencor, Inc. | 1.84B | -0.72% | 1,094,975 | 104.97M |
| 111 | ZBIO | Zenas BioPharma, Inc. | 1.82B | 3.60% | 881,856 | 1.00M |
| 112 | SEPN | Septerna, Inc. | 1.78B | -2.76% | 545,256 | 98.88M |
| 113 | GENB | Generate Biomedicines, Inc. | 1.77B | -8.12% | 1,394,808 | 26.48M |
| 114 | BRVE | Braveheart Bio, Inc. | 1.77B | 5.99% | 669,412 | - |
| 115 | NVAX | Novavax, Inc. | 1.75B | -1.94% | 3,149,724 | 413.80M |
| 116 | NTLA | Intellia Therapeutics, Inc. | 1.70B | 0.50% | 7,448,337 | 59.51M |
| 117 | STOK | Stoke Therapeutics, Inc. | 1.68B | 0.04% | 1,161,179 | 27.59M |
| 118 | SNDX | Syndax Pharmaceuticals, Inc. | 1.63B | -3.09% | 1,431,595 | 252.25M |
| 119 | QURE | uniQure N.V. | 1.62B | -3.27% | 3,185,838 | 18.67M |
| 120 | NKTR | Nektar Therapeutics | 1.60B | -22.39% | 6,271,723 | 54.59M |
| 121 | OCUL | Ocular Therapeutix, Inc. | 1.60B | -4.95% | 4,514,297 | 52.06M |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.58B | -2.29% | 326,777 | 20.00M |
| 123 | IMCR | Immunocore Holdings plc | 1.57B | 0.83% | 769,657 | 430.78M |
| 124 | GHRS | GH Research PLC | 1.57B | -2.64% | 255,125 | - |
| 125 | TSHA | Taysha Gene Therapies, Inc. | 1.54B | -2.67% | 3,847,674 | 5.49M |
| 126 | INVA | Innoviva, Inc. | 1.48B | -3.11% | 927,091 | 440.00M |
| 127 | MAZE | Maze Therapeutics, Inc. | 1.48B | -1.95% | 589,350 | 20.00M |
| 128 | ANAB | AnaptysBio, Inc. | 1.45B | -3.24% | 512,335 | 106.09M |
| 129 | NBTX | Nanobiotix S.A. | 1.45B | -10.46% | 192,409 | 13.15M |
| 130 | COAG | Hemab Therapeutics Holdings, Inc. | 1.45B | 0.71% | 437,788 | - |
| 131 | RARE | Ultragenyx Pharmaceutical Inc. | 1.45B | -1.86% | 4,117,609 | 717.00M |
| 132 | TYRA | Tyra Biosciences, Inc. | 1.44B | -3.93% | 889,700 | - |
| 133 | INBX | Inhibrx Biosciences, Inc. | 1.44B | -2.15% | 216,611 | 1.30M |
| 134 | AAPG | Ascentage Pharma Group International | 1.44B | -2.51% | 4,324 | 94.61M |
| 135 | KLRA | Kailera Therapeutics, Inc. | 1.43B | -3.42% | 2,188,038 | - |
| 136 | AVBP | ArriVent BioPharma, Inc. | 1.43B | -4.46% | 591,789 | - |
| 137 | KRSA | Korsana Biosciences, Inc. | 1.42B | -2.50% | 14,738 | - |
| 138 | DRTS | Alpha Tau Medical Ltd. | 1.34B | -2.68% | 379,966 | - |
| 139 | OMER | Omeros Corporation | 1.34B | -2.99% | 1,236,860 | 38.42M |
| 140 | KARD | Kardigan, Inc. | 1.33B | -3.39% | 913,886 | - |
| 141 | ORIC | ORIC Pharmaceuticals, Inc. | 1.30B | -7.05% | 1,770,891 | - |
| 142 | SVRA | Savara Inc. | 1.28B | -2.23% | 2,549,670 | - |
| 143 | MNKD | MannKind Corporation | 1.27B | 1.28% | 10,190,767 | 393.63M |
| 144 | REPL | Replimune Group, Inc. | 1.27B | 1.59% | 2,518,910 | - |
| 145 | DMRA | Damora Therapeutics, Inc. | 1.25B | -4.93% | 354,653 | - |
| 146 | AVLN | Avalyn Pharma Inc. | 1.22B | -3.76% | 423,592 | - |
| 147 | TRAX | First Tracks Biotherapeutics, Inc. | 1.21B | -4.29% | 564,143 | - |
| 148 | BCAX | Bicara Therapeutics Inc. | 1.20B | -2.20% | 698,047 | - |
| 149 | LBRX | LB Pharmaceuticals Inc | 1.20B | -2.87% | 278,892 | - |
| 150 | IMTX | Immatics N.V. | 1.15B | -3.87% | 639,726 | 47.65M |
| 151 | LTGO | Latigo Biotherapeutics, Inc. | 1.11B | -0.06% | 436,708 | - |
| 152 | VOR | Vor Biopharma Inc. | 1.07B | -5.35% | 876,786 | - |
| 153 | JANX | Janux Therapeutics, Inc. | 1.04B | -1.85% | 837,559 | 24.00M |
| 154 | AKTS | Aktis Oncology, Inc. | 1.03B | -4.88% | 305,211 | 10.06M |
| 155 | MGTX | MeiraGTx Holdings plc | 1.02B | -3.09% | 1,066,045 | 397.50M |
| 156 | ANL | Adlai Nortye Group Ltd. | 1.01B | -1.50% | 124,785 | 18.06M |
| 157 | SPTX | Seaport Therapeutics, Inc. | 1.01B | -6.05% | 330,192 | - |
| 158 | ANRO | Alto Neuroscience, Inc. | 993.22M | -0.86% | 575,794 | - |
| 159 | ODTX | Odyssey Therapeutics, Inc. | 978.49M | -8.10% | 308,443 | 99.00K |
| 160 | MLTX | MoonLake Immunotherapeutics | 976.17M | -1.97% | 1,305,276 | - |
| 161 | GLUE | Monte Rosa Therapeutics, Inc. | 960.63M | -5.62% | 2,868,605 | 28.73M |
| 162 | KURA | Kura Oncology, Inc. | 947.43M | -0.56% | 2,430,803 | 77.23M |
| 163 | APMD | Apnimed, Inc. | 938.36M | 2.88% | 747,561 | 115.12M |
| 164 | CGEM | Cullinan Therapeutics, Inc. | 935.07M | -5.34% | 911,809 | - |
| 165 | ALMS | Alumis Inc. | 933.23M | -2.44% | 2,131,438 | 7.40M |
| 166 | CRVS | Corvus Pharmaceuticals, Inc. | 919.44M | -5.12% | 1,308,975 | - |
| 167 | SLBT | SL Science Holding Limited | 912.43M | -5.88% | 34,295 | 3.27M |
| 168 | ABUS | Arbutus Biopharma Corporation | 902.19M | -4.60% | 16,120,397 | 181.72M |
| 169 | SGP | SpyGlass Pharma, Inc. | 886.37M | 1.92% | 101,101 | - |
| 170 | RIGL | Rigel Pharmaceuticals, Inc. | 877.39M | -2.45% | 234,999 | 276.79M |
| 171 | JBIO | Jade Biosciences, Inc. | 875.74M | -1.99% | 1,071,685 | - |
| 172 | HELP | Cybin Inc. | 870.15M | -3.09% | 1,328,307 | - |
| 173 | SANA | Sana Biotechnology, Inc. | 865.15M | -0.86% | 3,770,570 | - |
| 174 | IMMX | Immix Biopharma, Inc. | 848.10M | -1.73% | 1,648,322 | - |
| 175 | ARDX | Ardelyx, Inc. | 842.25M | -1.17% | 4,107,365 | 450.89M |
| 176 | DNA | Ginkgo Bioworks Holdings, Inc. | 841.75M | -2.57% | 2,915,923 | 132.42M |
| 177 | OBX | Obsidian Therapeutics, Inc. | 822.81M | -2.99% | 299,804 | - |
| 178 | ATTO | Attovia Therapeutics, Inc. | 812.14M | 3.79% | 530,816 | 1.80M |
| 179 | IVA | Inventiva S.A. | 810.04M | -6.23% | 5,325,132 | 2.81M |
| 180 | LXRX | Lexicon Pharmaceuticals, Inc. | 809.82M | -2.93% | 2,273,033 | 41.47M |
| 181 | AVTX | Avalo Therapeutics, Inc. | 801.77M | -2.48% | 932,393 | 59.00K |
| 182 | ANNX | Annexon, Inc. | 781.07M | -2.60% | 3,919,070 | - |
| 183 | CADL | Candel Therapeutics, Inc. | 777.43M | -2.68% | 1,037,610 | - |
| 184 | GERN | Geron Corporation | 777.39M | -1.63% | 13,255,441 | 204.56M |
| 185 | ACHV | Achieve Life Sciences, Inc. | 774.86M | -6.92% | 1,153,538 | - |
| 186 | DSGN | Design Therapeutics, Inc. | 766.00M | -2.63% | 346,591 | - |
| 187 | FDMT | 4D Molecular Therapeutics, Inc. | 764.58M | -3.28% | 655,464 | 92.01M |
| 188 | WVE | Wave Life Sciences, Inc. | 764.55M | 4.86% | 5,418,860 | 65.37M |
| 189 | SLDB | Solid Biosciences Inc. | 748.43M | -3.46% | 1,582,202 | - |
| 190 | GYRE | Gyre Therapeutics, Inc. | 742.24M | -4.50% | 139,999 | 109.82M |
| 191 | FTH | Faeth Therapeutics, Inc. | 730.51M | -4.94% | 268,483 | - |
| 192 | OABI | OmniAb, Inc. | 725.50M | 0.60% | 1,981,635 | 38.46M |
| 193 | OLMA | Olema Pharmaceuticals, Inc. | 723.61M | -4.28% | 1,009,506 | - |
| 194 | VSTM | Verastem, Inc. | 715.45M | -1.86% | 1,762,501 | 87.53M |
| 195 | PHAR | Pharming Group N.V. | 705.87M | -0.40% | 12,090 | 366.48M |
| 196 | STTK | Shattuck Labs, Inc. | 686.48M | 0.29% | 2,023,932 | 1.00M |
| 197 | MDXG | MiMedx Group, Inc. | 676.33M | -0.43% | 1,189,164 | 355.17M |
| 198 | NVCT | Nuvectis Pharma, Inc. | 675.09M | -1.89% | 168,273 | - |
| 199 | ETRA | Electra Therapeutics, Inc. | 670.35M | -5.07% | 1,255,362 | - |
| 200 | SGMT | Sagimet Biosciences Inc. | 664.41M | -5.16% | 2,008,407 | - |
| 201 | DBVT | DBV Technologies S.A. | 653.00M | -4.68% | 564,493 | 5.04M |
| 202 | ACRS | Aclaris Therapeutics, Inc. | 649.15M | -16.16% | 5,177,064 | 8.22M |
| 203 | SLN | Silence Therapeutics plc | 644.84M | -2.01% | 1,578,911 | 615.00K |
| 204 | CLYM | Climb Bio, Inc. | 635.82M | -3.49% | 953,156 | - |
| 205 | AURA | Aura Biosciences, Inc. | 626.38M | -3.82% | 807,346 | - |
| 206 | CBIO | Crescent Biopharma, Inc. | 610.34M | -2.26% | 300,909 | 11.88M |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 604.53M | -7.20% | 1,301,121 | 136.07M |
| 208 | BLSM | BlossomHill Therapeutics, Inc. | 590.88M | -0.27% | 152,583 | - |
| 209 | CRMD | CorMedix Inc. | 578.35M | -3.64% | 1,052,574 | 462.25M |
| 210 | CTMX | CytomX Therapeutics, Inc. | 573.08M | -3.31% | 2,697,830 | 18.30M |
| 211 | PHAT | Phathom Pharmaceuticals, Inc. | 562.37M | -3.01% | 1,059,776 | 239.66M |
| 212 | VALN | Valneva SE | 557.50M | -4.68% | 34,511 | 163.30M |
| 213 | YDES | YD Bio Limited | 553.19M | 5.26% | 267,881 | 1.24M |
| 214 | OCS | Oculis Holding AG | 540.77M | -6.21% | 578,446 | 1.45M |
| 215 | ALT | Altimmune, Inc. | 536.87M | -3.50% | 3,593,559 | 31.00K |
| 216 | MPLT | MapLight Therapeutics, Inc. | 535.19M | -5.50% | 432,225 | - |
| 217 | ALLO | Allogene Therapeutics, Inc. | 532.06M | -3.75% | 4,606,898 | 4.64M |
| 218 | PRME | Prime Medicine, Inc. | 531.93M | -2.13% | 2,829,802 | 4.07M |
| 219 | NGNE | Neurogene Inc. | 531.30M | -4.57% | 182,600 | 925.00K |
| 220 | MNPR | Monopar Therapeutics Inc. | 523.35M | -2.13% | 130,810 | - |
| 221 | CAPR | Capricor Therapeutics, Inc. | 519.76M | -5.60% | 3,875,878 | 11.13M |
| 222 | EPRX | Eupraxia Pharmaceuticals Inc. | 517.54M | -13.96% | 3,645,197 | - |
| 223 | PROK | ProKidney Corp. | 516.97M | 3.01% | 1,511,177 | 818.00K |
| 224 | PBYI | Puma Biotechnology, Inc. | 507.94M | -0.91% | 518,407 | 231.24M |
| 225 | ENTX | Entera Bio Ltd. | 500.38M | -0.69% | 640,880 | 42.00K |
| 226 | AUTL | Autolus Therapeutics plc | 492.40M | -4.64% | 1,458,882 | 117.39M |
| 227 | DRUG | Bright Minds Biosciences Inc. | 491.05M | -1.22% | 166,987 | - |
| 228 | RGNX | REGENXBIO Inc. | 489.82M | -1.46% | 1,705,151 | 174.48M |
| 229 | CTNM | Contineum Therapeutics, Inc. | 488.70M | -3.20% | 773,993 | - |
| 230 | ARVN | Arvinas, Inc. | 485.82M | -4.01% | 807,322 | 316.70M |
| 231 | OVID | Ovid Therapeutics Inc. | 474.57M | -2.41% | 1,349,464 | 1.58M |
| 232 | ASMB | Assembly Biosciences, Inc. | 467.89M | -2.17% | 350,803 | 74.85M |
| 233 | DMAC | DiaMedica Therapeutics Inc. | 450.28M | 0.97% | 234,219 | - |
| 234 | TECX | Tectonic Therapeutic, Inc. | 443.18M | -2.66% | 343,508 | - |
| 235 | PRTA | Prothena Corporation plc | 438.42M | 1.91% | 457,092 | 54.53M |
| 236 | RZLT | Rezolute, Inc. | 426.93M | -1.69% | 981,719 | - |
| 237 | AGMB | AgomAb Therapeutics NV | 425.99M | -22.07% | 639,377 | - |
| 238 | SPRY | ARS Pharmaceuticals, Inc. | 409.72M | -4.41% | 1,971,566 | 116.93M |
| 239 | AVIR | Atea Pharmaceuticals, Inc. | 409.04M | -2.11% | 408,661 | - |
| 240 | KYTX | Kyverna Therapeutics, Inc. | 403.22M | -4.12% | 788,497 | - |
| 241 | EIKN | Eikon Therapeutics, Inc. | 401.36M | -7.84% | 624,565 | - |
| 242 | ZURA | Zura Bio Limited | 396.73M | -0.48% | 2,913,586 | - |
| 243 | TTRX | Turn Therapeutics Inc. | 396.48M | -7.51% | 122,090 | - |
| 244 | VTVT | vTv Therapeutics Inc. | 395.73M | 3.27% | 34,272 | 36.84M |
| 245 | RLMD | Relmada Therapeutics, Inc. | 390.41M | -2.92% | 1,358,477 | - |
| 246 | PRLD | Prelude Therapeutics Incorporated | 390.35M | -3.07% | 502,503 | 22.42M |
| 247 | EDIT | Editas Medicine, Inc. | 387.02M | -1.95% | 1,544,254 | 47.01M |
| 248 | CCCC | C4 Therapeutics, Inc. | 386.30M | -5.71% | 1,892,052 | 35.04M |
| 249 | OBIO | Orchestra BioMed Holdings, Inc. | 381.67M | 2.09% | 389,941 | 31.98M |
| 250 | GALT | Galectin Therapeutics Inc. | 379.19M | -3.09% | 327,425 | - |
| 251 | ARCT | Arcturus Therapeutics Holdings Inc. | 375.47M | -3.51% | 497,333 | 29.37M |
| 252 | IRD | Opus Genetics, Inc. | 375.21M | -6.82% | 1,873,945 | 9.86M |
| 253 | AGEN | Agenus Inc. | 375.02M | -16.11% | 1,951,998 | 132.69M |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 373.97M | -2.58% | 331,488 | 65.26M |
| 255 | FENC | Fennec Pharmaceuticals Inc. | 362.24M | -3.00% | 130,152 | 59.22M |
| 256 | SRZN | Surrozen, Inc. | 352.61M | -6.77% | 438,531 | 11.51M |
| 257 | IKT | Inhibikase Therapeutics, Inc. | 351.40M | -6.08% | 476,971 | 1.00 |
| 258 | OCGN | Ocugen, Inc. | 339.11M | -2.91% | 5,058,462 | 4.58M |
| 259 | BNTC | Benitec Biopharma Inc. | 334.18M | -4.20% | 103,096 | - |
| 260 | ARTV | Artiva Biotherapeutics, Inc. | 331.96M | -4.63% | 444,373 | 251.00K |
| 261 | SCTX | Scribe Therapeutics Inc. | 325.15M | -6.71% | 670,000 | 33.30M |
| 262 | CABA | Cabaletta Bio, Inc. | 320.44M | -1.56% | 8,535,361 | - |
| 263 | LRMR | Larimar Therapeutics, Inc. | 319.41M | -4.23% | 858,311 | - |
| 264 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 315.89M | -3.90% | 1,363,713 | - |
| 265 | VOGX | Vogenx, Inc. | 297.99M | -11.98% | 94,599 | - |
| 266 | LXEO | Lexeo Therapeutics, Inc. | 296.99M | 7.10% | 2,886,509 | - |
| 267 | IPSC | Century Therapeutics, Inc. | 291.53M | -5.85% | 622,506 | 109.16M |
| 268 | VNDA | Vanda Pharmaceuticals Inc. | 290.83M | -2.04% | 1,351,733 | 215.72M |
| 269 | CUVL | Clinuvel Pharmaceuticals Limited | 287.99M | -5.03% | 10,432 | 65.05M |
| 270 | ABEO | Abeona Therapeutics Inc. | 286.49M | -4.57% | 1,475,813 | 25.52M |
| 271 | RCKT | Rocket Pharmaceuticals, Inc. | 284.32M | -1.52% | 2,091,969 | - |
| 272 | INDP | Indaptus Therapeutics, Inc. | 282.47M | -7.83% | 479,388 | - |
| 273 | FULC | Fulcrum Therapeutics, Inc. | 280.77M | -0.54% | 1,227,541 | 80.00M |
| 274 | XFOR | X4 Pharmaceuticals, Inc. | 280.59M | -2.41% | 501,492 | 15.85M |
| 275 | ACIU | AC Immune SA | 279.39M | 7.25% | 352,698 | 21.67M |
| 276 | EYPT | EyePoint, Inc. | 278.47M | -1.22% | 2,862,705 | 2.79M |
| 277 | SABS | SAB Biotherapeutics, Inc. | 278.42M | -3.47% | 426,589 | 114.70K |
| 278 | UPB | Upstream Bio, Inc. | 276.05M | -4.36% | 832,378 | 3.16M |
| 279 | FATE | Fate Therapeutics, Inc. | 275.59M | -2.95% | 812,977 | 6.49M |
| 280 | STRO | Sutro Biopharma, Inc. | 264.80M | -0.87% | 196,926 | 45.70M |
| 281 | VCRE | Vicore Pharma Holding AB (publ) | 263.64M | -0.84% | 41,068 | 412.09K |
| 282 | EVMN | Evommune, Inc. | 261.67M | -12.71% | 1,525,173 | 10.00M |
| 283 | PYXS | Pyxis Oncology, Inc. | 261.61M | -6.01% | 2,604,632 | 11.04M |
| 284 | IMRX | Immuneering Corporation | 260.73M | -1.59% | 538,181 | - |
| 285 | GLSI | Greenwich LifeSciences, Inc. | 254.67M | -3.88% | 121,605 | - |
| 286 | IFRX | InflaRx N.V. | 252.00M | -5.00% | 369,956 | -11.54K |
| 287 | PALI | Palisade Bio, Inc. | 249.21M | 5.93% | 2,645,190 | 500.00K |
| 288 | BCYC | Bicycle Therapeutics plc | 249.17M | -3.26% | 379,977 | 61.21M |
| 289 | ZNTL | Zentalis Pharmaceuticals, Inc. | 246.62M | -5.96% | 1,898,774 | 26.87M |
| 290 | QTTB | Q32 Bio Inc. | 245.60M | -0.24% | 3,087,592 | 53.74M |
| 291 | CAMP | Camp4 Therapeutics Corporation | 240.97M | -4.95% | 994,722 | 4.22M |
| 292 | IVVD | Invivyd, Inc. | 240.67M | -6.16% | 5,459,831 | 58.37M |
| 293 | SLGL | Sol-Gel Technologies Ltd. | 239.00M | -1.72% | 32,764 | 1.80M |
| 294 | LYEL | Lyell Immunopharma, Inc. | 230.59M | -3.88% | 115,248 | 27.00K |
| 295 | SION | Sionna Therapeutics, Inc. | 230.58M | -3.04% | 1,059,875 | - |
| 296 | PRQR | ProQR Therapeutics N.V. | 230.03M | -1.81% | 1,970,529 | 21.05M |
| 297 | MGNX | MacroGenics, Inc. | 229.32M | -6.74% | 656,628 | 175.14M |
| 298 | LCTX | Lineage Cell Therapeutics, Inc. | 228.68M | -5.39% | 1,651,931 | 13.08M |
| 299 | KROS | Keros Therapeutics, Inc. | 223.25M | -1.23% | 140,170 | 15.01M |
| 300 | CGEN | Compugen Ltd. | 221.65M | -1.68% | 173,347 | 74.00M |
| 301 | YARW | Yarrow Bioscience, Inc. | 219.58M | 4.80% | 35,406 | - |
| 302 | RNAC | Cartesian Therapeutics, Inc. | 218.44M | 0.14% | 175,756 | 1.48M |
| 303 | PLX | Protalix BioTherapeutics, Inc. | 215.93M | -2.90% | 1,589,281 | 80.62M |
| 304 | WHWK | Whitehawk Therapeutics, Inc. | 214.35M | - | 208,071 | 7.15M |
| 305 | ANTX | AN2 Therapeutics, Inc. | 212.08M | 5.64% | 509,440 | - |
| 306 | ALEC | Alector, Inc. | 207.68M | 0.54% | 774,594 | 13.86M |
| 307 | TRDA | Entrada Therapeutics, Inc. | 204.80M | -10.55% | 425,139 | 4.69M |
| 308 | NAUT | Nautilus Biotechnology, Inc. | 199.79M | 10.56% | 8,507,795 | 190.00K |
| 309 | ELDN | Eledon Pharmaceuticals, Inc. | 198.07M | -3.75% | 616,502 | - |
| 310 | ADAG | Adagene Inc. | 196.73M | -8.44% | 278,281 | 9.29M |
| 311 | ACOG | Alpha Cognition Inc. | 189.47M | -3.33% | 88,394 | 15.26M |
| 312 | NGEN | NervGen Pharma Corp. | 189.24M | -7.85% | 1,051,256 | - |
| 313 | ORMP | Oramed Pharmaceuticals Inc. | 186.36M | -4.07% | 272,601 | 2.00M |
| 314 | CUE | Cue Biopharma, Inc. | 183.43M | -2.40% | 183,433 | 37.66M |
| 315 | NKTX | Nkarta, Inc. | 183.36M | -2.29% | 402,298 | - |
| 316 | MSLE | Satellos Bioscience Inc. | 180.00M | - | 79,977 | - |
| 317 | ALXO | ALX Oncology Holdings Inc. | 179.76M | -6.47% | 1,481,501 | - |
| 318 | CHRS | Coherus Oncology, Inc. | 179.22M | -4.13% | 709,396 | 50.94M |
| 319 | MDWD | MediWound Ltd. | 175.58M | -1.23% | 81,541 | 11.86M |
| 320 | AVXL | Anavex Life Sciences Corp. | 175.20M | -6.44% | 2,342,819 | - |
| 321 | DTIL | Precision BioSciences, Inc. | 174.72M | 1.12% | 242,170 | 45.06M |
| 322 | CNTN | Canton Strategic Holdings, Inc. | 174.10M | -8.00% | 721,762 | 1.50M |
| 323 | FHTX | Foghorn Therapeutics Inc. | 173.41M | -18.21% | 13,378,302 | 36.74M |
| 324 | VRXA | Veraxa Biotech AG | 168.28M | -4.80% | 65,564 | 29.54K |
| 325 | VYGR | Voyager Therapeutics, Inc. | 164.83M | -0.19% | 600,093 | 34.46M |
| 326 | TARA | Protara Therapeutics, Inc. | 163.10M | -9.51% | 4,999,036 | - |
| 327 | CMPX | Compass Therapeutics, Inc. | 162.28M | -13.36% | 10,067,697 | 850.00K |
| 328 | TNXP | Tonix Pharmaceuticals Holding Corp. | 158.30M | -5.24% | 477,043 | 29.10M |
| 329 | NBP | NovaBridge Biosciences | 155.44M | -1.83% | 342,369 | - |
| 330 | NERV | Minerva Neurosciences, Inc. | 154.22M | -3.58% | 89,216 | - |
| 331 | MOLN | Molecular Partners AG | 154.03M | - | - | 856.30K |
| 332 | PEPG | PepGen Inc. | 153.06M | -8.68% | 783,001 | - |
| 333 | MENS | Jyong Biotech Ltd. | 150.69M | -0.98% | 31,273 | - |
| 334 | ABOS | Acumen Pharmaceuticals, Inc. | 149.70M | -6.76% | 833,409 | - |
| 335 | CDXS | Codexis, Inc. | 148.93M | -2.16% | 752,102 | 77.68M |
| 336 | TLSA | Tiziana Life Sciences Ltd | 147.41M | 2.70% | 697,718 | - |
| 337 | KRRO | Korro Bio, Inc. | 142.99M | -2.02% | 88,782 | 2.38M |
| 338 | IPHA | Innate Pharma S.A. | 142.42M | -2.45% | 64,052 | 11.21M |
| 339 | OTLK | Outlook Therapeutics, Inc. | 139.98M | 0.26% | 7,068,831 | -1.16M |
| 340 | HUMA | Humacyte, Inc. | 139.70M | -2.86% | 2,995,287 | 2.12M |
| 341 | RNA | Atrium Therapeutics, Inc. | 139.24M | -1.69% | 395,724 | 35.84M |
| 342 | ENGN | enGene Therapeutics Inc. | 132.69M | -1.00% | 903,045 | - |
| 343 | PMVP | PMV Pharmaceuticals, Inc. | 132.15M | 4.79% | 1,647,432 | - |
| 344 | CRBU | Caribou Biosciences, Inc. | 130.79M | -3.94% | 687,396 | 10.04M |
| 345 | KZIA | Kazia Therapeutics Limited | 129.77M | -1.35% | 132,204 | 1.27M |
| 346 | SPRB | Spruce Biosciences, Inc. | 128.67M | -7.84% | 79,630 | 697.00K |
| 347 | TNYA | Tenaya Therapeutics, Inc. | 126.85M | -6.28% | 4,755,436 | 1.34M |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 126.74M | -3.09% | 1,068,824 | - |
| 349 | HURA | TuHURA Biosciences, Inc. | 126.18M | -5.71% | 273,597 | - |
| 350 | INO | Inovio Pharmaceuticals, Inc. | 125.11M | -0.82% | 1,939,664 | 65.34K |
| 351 | CBUS | Cibus, Inc. | 124.58M | 1.24% | 106,403 | 4.35M |
| 352 | NRXP | NRx Pharmaceuticals, Inc. | 123.30M | -2.40% | 625,975 | 3.39M |
| 353 | ARMP | Armata Pharmaceuticals, Inc. | 123.07M | -9.81% | 76,458 | 5.54M |
| 354 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 122.62M | -7.04% | 802,994 | - |
| 355 | SEER | Seer, Inc. | 121.82M | -1.35% | 311,947 | 14.22M |
| 356 | LENZ | LENZ Therapeutics, Inc. | 119.08M | -1.30% | 738,896 | 21.48M |
| 357 | IMUX | Immunic, Inc. | 117.89M | -7.10% | 559,787 | - |
| 358 | AARD | Aardvark Therapeutics, Inc. | 115.33M | - | 47,844 | - |
| 359 | MIST | Milestone Pharmaceuticals Inc. | 114.94M | -5.78% | 725,594 | 2.34M |
| 360 | GNLX | Genelux Corporation | 112.93M | -0.40% | 200,938 | 8.00K |
| 361 | COYA | Coya Therapeutics, Inc. | 110.96M | -5.59% | 116,133 | 8.02M |
| 362 | RANI | Rani Therapeutics Holdings, Inc. | 110.89M | 0.57% | 484,900 | 4.88M |
| 363 | TENX | Tenax Therapeutics, Inc. | 110.55M | 2.12% | 2,291,820 | - |
| 364 | VANI | Vivani Medical, Inc. | 110.05M | -1.61% | 63,755 | - |
| 365 | PYPD | PolyPid Ltd. | 109.07M | 1.90% | 118,780 | - |
| 366 | BDTX | Black Diamond Therapeutics, Inc. | 108.01M | -0.27% | 399,124 | 70.00M |
| 367 | TVGN | Tevogen Inc. | 105.75M | 1.51% | 6,537 | - |
| 368 | CLLS | Cellectis S.A. | 105.59M | -7.28% | 140,737 | 63.82M |
| 369 | NMRA | Neumora Therapeutics, Inc. | 103.34M | -7.75% | 2,849,876 | - |
| 370 | OKUR | OnKure Therapeutics, Inc. | 102.86M | -6.79% | 2,082,157 | - |
| 371 | PLYX | Polaryx Therapeutics, Inc. | 100.69M | -2.42% | 58,970 | - |
| 372 | EQ | Equillium, Inc. | 97.65M | -5.23% | 529,400 | 4.39M |
| 373 | ANIX | Anixa Biosciences, Inc. | 96.30M | -5.46% | 290,391 | - |
| 374 | BMEA | Biomea Fusion, Inc. | 94.23M | -2.26% | 1,069,850 | - |
| 375 | CNXU | Conexeu Sciences Inc. | 93.65M | -7.00% | 95,785 | - |
| 376 | CRDF | Cardiff Oncology, Inc. | 91.80M | -2.48% | 298,499 | 508.00K |
| 377 | NRXS | NeurAxis, Inc. | 90.04M | -2.71% | 134,876 | 5.32M |
| 378 | NTRB | Nutriband Inc. | 89.47M | -2.13% | 42,174 | 1.62M |
| 379 | RLYB | Rallybio Corporation | 89.00M | -2.56% | 7,081 | 646.00K |
| 380 | ICCC | ImmuCell Corporation | 87.19M | -2.04% | 39,532 | 30.68M |
| 381 | ACRV | Acrivon Therapeutics, Inc. | 86.14M | -1.95% | 316,874 | - |
| 382 | ATRA | Atara Biotherapeutics, Inc. | 84.92M | -0.47% | 90,929 | 6.19M |
| 383 | CGTX | Cognition Therapeutics, Inc. | 84.75M | -7.17% | 792,158 | - |
| 384 | PMN | ProMIS Neurosciences, Inc. | 84.12M | -13.55% | 102,139 | - |
| 385 | ONCY | Oncolytics Biotech Inc. | 81.76M | -4.04% | 693,107 | - |
| 386 | TELO | Telomir Pharmaceuticals, Inc. | 80.47M | -2.50% | 59,755 | - |
| 387 | MNOV | MediciNova, Inc. | 80.23M | -2.69% | 263,257 | 920.48K |
| 388 | PTHS | Pelthos Therapeutics Inc. | 77.91M | -3.14% | 44,590 | 43.30M |
| 389 | ALDX | Aldeyra Therapeutics, Inc. | 77.82M | 4.88% | 1,211,432 | - |
| 390 | VRCA | Verrica Pharmaceuticals Inc. | 77.56M | -5.84% | 55,307 | 30.32M |
| 391 | NTHI | NeOnc Technologies Holdings, Inc. | 76.06M | -10.13% | 161,063 | 39.99K |
| 392 | GANX | Gain Therapeutics, Inc. | 75.07M | -0.58% | 497,408 | - |
| 393 | OSTX | OS Therapies Incorporated | 74.26M | 0.63% | 329,638 | - |
| 394 | RNTX | Rein Therapeutics Inc. | 73.51M | 5.98% | 1,108,050 | - |
| 395 | SPRO | Spero Therapeutics, Inc. | 73.38M | 4.13% | 1,039,211 | 47.00M |
| 396 | GUTS | Fractyl Health, Inc. | 71.65M | -17.32% | 5,547,985 | 3.00K |
| 397 | ACET | Adicet Bio, Inc. | 71.48M | -7.00% | 149,042 | - |
| 398 | IBIO | iBio, Inc. | 71.38M | -5.93% | 341,275 | 100.00K |
| 399 | MAIA | MAIA Biotechnology, Inc. | 71.17M | -0.85% | 781,506 | - |
| 400 | OKYO | OKYO Pharma Limited | 70.32M | 3.88% | 16,903 | - |
| 401 | RNXT | RenovoRx, Inc. | 69.95M | -0.64% | 404,025 | 1.98M |
| 402 | CING | Cingulate Inc. | 69.07M | -4.04% | 48,982 | - |
| 403 | FBIO | Fortress Biotech, Inc. | 69.04M | -3.27% | 286,249 | 68.47M |
| 404 | CSBR | Champions Oncology, Inc. | 67.92M | -2.40% | 2,422 | 60.66M |
| 405 | KLRS | Kalaris Therapeutics, Inc. | 67.84M | -1.38% | 58,622 | - |
| 406 | HRTX | Heron Therapeutics, Inc. | 67.57M | 13.52% | 3,182,115 | 151.18M |
| 407 | XBIT | XBiotech Inc. | 67.07M | 0.46% | 13,563 | - |
| 408 | GOSS | Gossamer Bio, Inc. | 66.79M | -7.76% | 352,082 | 53.29M |
| 409 | PLRX | Pliant Therapeutics, Inc. | 65.02M | -2.78% | 379,553 | - |
| 410 | INKT | MiNK Therapeutics, Inc. | 64.96M | 1.43% | 26,676 | - |
| 411 | ALPS | Alps Group Inc | 64.90M | -2.01% | 7,228 | 3.74M |
| 412 | ELOX | Eloxx Pharmaceuticals, Inc. | 63.41M | 2.61% | 10,872 | - |
| 413 | HYFT | MindWalk Holdings Corp. | 62.66M | 0.38% | 117,084 | 11.57M |
| 414 | CNTB | Connect Biopharma Holdings Limited | 61.70M | -10.94% | 7,941,161 | 2.95M |
| 415 | BOLD | Boundless Bio, Inc. | 58.91M | 3.19% | 163,785 | - |
| 416 | XLO | Xilio Therapeutics, Inc. | 58.63M | -1.55% | 12,886 | 64.09M |
| 417 | MREO | Mereo BioPharma Group plc | 58.59M | -8.73% | 1,602,502 | 500.00K |
| 418 | ATHE | Alterity Therapeutics Limited | 58.06M | -4.38% | 23,201 | 2.50M |
| 419 | CLNN | Clene Inc. | 57.14M | -1.47% | 100,034 | 197.00K |
| 420 | HYPD | Hyperion DeFi, Inc. | 56.87M | -2.27% | 252,662 | 1.40M |
| 421 | BSEM | BioStem Technologies, Inc. | 54.80M | -0.65% | 90,841 | 34.59M |
| 422 | EDSA | Edesa Biotech, Inc. | 54.18M | -4.75% | 15,489 | - |
| 423 | INMB | INmune Bio Inc. | 53.56M | -1.03% | 340,815 | 50.00K |
| 424 | EXOZ | eXoZymes, Inc. | 53.46M | -1.20% | 1,000 | -700.00 |
| 425 | IMA | ImageneBio, Inc. | 51.99M | - | 11,826 | 800.00K |
| 426 | APLM | Apollomics, Inc. | 51.09M | -6.75% | 1,165 | 8.84M |
| 427 | ELTX | Elicio Therapeutics, Inc. | 50.46M | 5.49% | 311,260 | - |
| 428 | ANVS | Annovis Bio, Inc. | 49.85M | -7.87% | 1,201,823 | - |
| 429 | SER | Serina Therapeutics, Inc. | 49.53M | -2.50% | 46,768 | 130.00K |
| 430 | TIL | Instil Bio, Inc. | 49.07M | -0.07% | 5,202 | - |
| 431 | DWTX | Dogwood Therapeutics, Inc. | 48.61M | 5.93% | 26,518 | - |
| 432 | FLNA | Filana Therapeutics, Inc. | 46.62M | 8.92% | 2,804,697 | - |
| 433 | IBO | Impact BioMedical Inc. | 46.39M | -3.04% | 8,991 | 35.00K |
| 434 | CELU | Celularity Inc. | 44.78M | 2.22% | 142,148 | 18.97M |
| 435 | CRVO | CervoMed Inc. | 44.30M | -1.35% | 175,072 | 331.30K |
| 436 | VERU | Veru Inc. | 43.31M | -4.51% | 70,679 | 16.89M |
| 437 | GRCE | Grace Therapeutics, Inc. | 42.91M | -5.12% | 344,209 | - |
| 438 | HOWL | Werewolf Therapeutics, Inc. | 42.84M | -4.42% | 299,327 | 21.00M |
| 439 | LITS | Lite Strategy, Inc. | 41.81M | 4.17% | 1,036,839 | - |
| 440 | MGX | Metagenomi Therapeutics, Inc. | 41.74M | 4.25% | 118,332 | 13.56M |
| 441 | LONA | LeonaBio, Inc. | 41.27M | 22.69% | 6,300,413 | - |
| 442 | PDSB | PDS Biotechnology Corporation | 39.52M | -5.94% | 3,726,186 | - |
| 443 | CVM | CEL-SCI Corporation | 36.76M | 1.46% | 810,344 | - |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 36.16M | 2.68% | 90,833 | 35.09M |
| 445 | BCTX | BriaCell Therapeutics Corp. | 35.90M | -3.97% | 61,609 | - |
| 446 | ALGS | Aligos Therapeutics, Inc. | 34.35M | -2.31% | 28,258 | 31.52M |
| 447 | IMMP | Immutep Limited | 33.67M | -2.37% | 11,136 | 13.79M |
| 448 | BYSI | BeyondSpring Inc. | 33.46M | 5.68% | 69,864 | 1.88M |
| 449 | NNVC | NanoViricides, Inc. | 32.16M | -3.08% | 205,156 | - |
| 450 | QNCX | Quince Therapeutics, Inc. | 31.20M | -1.06% | 20,921 | - |
| 451 | MCRB | Seres Therapeutics, Inc. | 29.13M | -12.54% | 247,329 | 1.88M |
| 452 | CNTX | Context Therapeutics Inc. | 28.89M | 4.66% | 1,140,605 | - |
| 453 | ATYR | aTyr Pharma, Inc. | 28.85M | -2.94% | 2,195,611 | 190.00K |
| 454 | IGC | IGC Pharma, Inc. | 27.91M | 0.41% | 459,170 | 1.11M |
| 455 | QNTM | Quantum BioPharma Ltd. | 27.70M | -4.86% | 82,709 | - |
| 456 | EVAX | Evaxion A/S | 26.52M | -3.05% | 38,121 | 7.49M |
| 457 | ABVC | ABVC BioPharma, Inc. | 26.44M | -3.77% | 138,628 | 797.92K |
| 458 | KYNB | Kyntra Bio, Inc. | 26.32M | -2.26% | 23,998 | 4.62M |
| 459 | RNAZ | TransCode Therapeutics, Inc. | 26.16M | -8.04% | 16,713 | - |
| 460 | PLRZ | Polyrizon Ltd. | 24.79M | -4.27% | 2,025 | - |
| 461 | GRDX | GridAI Technologies Corp. | 24.36M | -6.57% | 73,126 | - |
| 462 | NXTC | NextCure, Inc. | 22.70M | -1.00% | 46,588 | - |
| 463 | QNRX | Quoin Pharmaceuticals, Ltd. | 22.68M | 3.51% | 17,458 | - |
| 464 | ATOS | Atossa Therapeutics, Inc. | 22.65M | 16.41% | 113,600 | - |
| 465 | COCP | Cocrystal Pharma, Inc. | 21.96M | -0.87% | 68,045 | 330.00K |
| 466 | TCRX | TScan Therapeutics, Inc. | 21.52M | 0.95% | 624,804 | 7.11M |
| 467 | ACTU | Actuate Therapeutics, Inc. | 21.35M | 14.04% | 494,409 | - |
| 468 | PBM | Psyence Biomedical Ltd. | 20.90M | 0.37% | 14,963 | - |
| 469 | ESLA | Estrella Immunopharma, Inc. | 20.66M | 1.78% | 14,739 | - |
| 470 | JSPR | Jasper Therapeutics, Inc. | 19.90M | 3.10% | 294,573 | - |
| 471 | KPTI | Karyopharm Therapeutics Inc. | 19.66M | -28.95% | 2,659,951 | 146.62M |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 18.99M | -1.40% | 14,303 | 1.17M |
| 473 | RADX | Radiopharm Theranostics Limited | 18.02M | -8.64% | 48,044 | 9.34M |
| 474 | CLRB | Cellectar Biosciences, Inc. | 17.68M | 1.63% | 30,183 | - |
| 475 | MRKR | Marker Therapeutics, Inc. | 17.51M | -1.87% | 127,494 | 3.55M |
| 476 | AKTX | Akari Therapeutics, Plc | 17.21M | -4.95% | 28,605 | - |
| 477 | LPCN | Lipocine Inc. | 17.07M | -5.91% | 71,208 | 1.57M |
| 478 | NCEL | NewcelX Ltd. | 16.81M | -5.37% | 5,183 | - |
| 479 | ALLR | Allarity Therapeutics, Inc. | 16.55M | -0.95% | 74,354 | 345.00K |
| 480 | TVRD | Tvardi Therapeutics, Inc. | 16.54M | -0.80% | 332,652 | - |
| 481 | ICU | SeaStar Medical Holding Corporation | 16.53M | -4.82% | 28,372 | 1.71M |
| 482 | KPRX | Kiora Pharmaceuticals, Inc. | 16.42M | 0.78% | 16,774 | 20.00K |
| 483 | KTTA | Pasithea Therapeutics Corp. | 16.34M | -0.79% | 12,637 | - |
| 484 | PTN | Palatin Technologies, Inc. | 15.76M | 2.14% | 33,049 | 13.19M |
| 485 | DYAI | Dyadic International, Inc. | 15.65M | -3.37% | 82,645 | 3.80M |
| 486 | BCDA | BioCardia, Inc. | 15.44M | 0.99% | 205,872 | 3.00K |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 14.83M | 1.73% | 154,956 | 7.11M |
| 488 | AEON | AEON Biopharma, Inc. | 14.47M | -3.33% | 6,637,981 | - |
| 489 | NIKI | Niki BioSolutions, Inc. | 14.13M | -1.84% | 7,947 | - |
| 490 | INAB | IN8bio, Inc. | 13.80M | 5.26% | 78,466 | - |
| 491 | PASG | Passage Bio, Inc. | 13.52M | -6.64% | 26,483 | - |
| 492 | CNSY | Cerenome, Inc. | 13.51M | -4.81% | 1,168,954 | 4.20M |
| 493 | HIND | Vyome Holdings, Inc. | 13.48M | -0.52% | 9,003 | 129.73K |
| 494 | LSTA | Lisata Therapeutics, Inc. | 13.43M | 3.47% | 63,139 | 100.00K |
| 495 | TPST | Tempest Therapeutics, Inc. | 13.33M | -3.38% | 153,414 | - |
| 496 | DARE | Daré Bioscience, Inc. | 13.01M | -0.27% | 135,127 | 1.37M |
| 497 | LTRN | Lantern Pharma Inc. | 12.78M | -0.99% | 253,566 | - |
| 498 | PLUR | Pluri Inc. | 12.72M | 3.00% | 10,397 | 1.02M |
| 499 | BLRX | BioLineRx Ltd. | 12.59M | - | 7,576 | 1.39M |
| 500 | VTGN | Vistagen Therapeutics, Inc. | 12.54M | -8.19% | 2,030,982 | 2.50M |